Feature

Chris McCurdy, Ph.D., director of the CTSI's Translational Drug Development Core, develops a key compound to be used in program designed to help end addiction long-term.

We are excited to announce the addition of two exceptional individuals to our leadership team at CTSI. These new directors bring a wealth of experience and expertise that will further elevate our organization’s capacity for innovation and growth.

Deadline: October 20, 2023, by 5:00 p. m. The UF Clinical and Translational Science Institute provides intramural awards to support the growth of interdisciplinary and investigator-initiated clinical and translational research across UF’s broad range of scientific disciplines. This CTSI RFA will support pilot projects across the full spectrum of…

The Clinical and Translational Science Institute, or CTSI, hosted its annual Research Day on April 14 – an event that celebrated research excellence in clinical and translational science across the University of Florida and Florida State University, or UF+FSU, Clinical and Translational Science Award hub. The event consisted of…

On April 10, 2023, The UF Clinical and Translational Science Institute, or CTSI, hosted its very first LHS Research Day, an event dedicated to showcasing the latest in Learning Health Systems, or LHS, research across the University of Florida and its Academic Health Center. This inaugural event was well-attended and left standing room only as attendees gathered to hear opening remarks from UF Health leaders, keynote presentations from visiting scholars.

About the gcid program (PPT)…

OT researchers and partners have launched a new study to understand older adults’ perceptions and experiences with an autonomous shuttle.

The UF CTSI Learning Health System Initiative is hosting its first Research Day and Poster Session to recognize and celebrate the multidisciplinary research, quality improvement, and implementation efforts of students, trainees, faculty, and staff across the UF Health Science Center.

University of Florida Health is among 42 health systems nationwide chosen by the Patient-Centered Outcomes Research Institute to carry out pioneering initiatives to accelerate the implementation of practice-changing research results in clinical care to improve patient outcomes.

Duane Mitchell, M.D., Ph.D., has been named recipient of the inaugural Louis W. Sullivan, M.D., Award from the American Society for Clinical Investigation in recognition of his work to develop innovative immunotherapy treatments for brain cancer.